Ipsen Eligible For PEA-PME And Included In CAC® PME Index By Euronext

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ipsen (Paris:IPN) (Pink Sheets IPSEY) (Euronext: IPN; ADR: IPSEY) today confirmed its eligibility for the PEA-PME scheme, in accordance with the French decree n° 2014-283 of 4 March 2014. The Group complies with the thresholds set by the legislator for eligibility to the PEA-PME scheme, namely having less than 5 000 employees and total revenue below €1 500 million or total assets below €2 000 million. As a consequence, investment in company shares can be made through PEA-PME accounts, benefiting from the same tax advantages as the traditional Equity Savings Plan (PEA).

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC